Research

Controlling the dose of a liver transplant rejection drug reduces the risk of developing cancer

A multi-centre study, in which the Clínic-IDIBAPS participated, identified, in nearly 2,500 transplant patients, the main risk factors for the development of cancer, such as male sex, alcohol consumption, and smoking.

Related contents